Am J Physiol Cell Physiol Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 285: C48-C55, 2003. First published March 12, 2003; doi:10.1152/ajpcell.00561.2002
0363-6143/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/1/C48    most recent
00561.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Linder, N.
Right arrow Articles by Raivio, K. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Linder, N.
Right arrow Articles by Raivio, K. O.

CELLULAR METABOLISM

Posttranslational inactivation of human xanthine oxidoreductase by oxygen under standard cell culture conditions

Nina Linder, Eeva Martelin, Risto Lapatto, and Kari O. Raivio

Hospital for Children and Adolescents, Research Program for Developmental and Reproductive Biology, University of Helsinki, Biomedicum Helsinki, 00290 Helsinki, Finland

Submitted 2 December 2002 ; accepted in final form 28 February 2003

Xanthine oxidoreductase (XOR) catalyzes the final reactions of purine catabolism and may account for cell damage by producing reactive oxygen metabolites in cells reoxygenated after hypoxia. We found a three- to eightfold higher XOR activity in cultured human bronchial epithelial cells exposed to hypoxia (0.5–3% O2) compared with cells grown in normoxia (21% O2) but no difference in XOR protein or mRNA. XOR promoter constructs failed to respond to hypoxia. The cellular XOR activity at 3% O2 returned to basal levels when the cells were returned to 21% O2, and hyperoxia (95% O2) abolished enzyme activity with no change in XOR protein. Our data suggest reversible enzyme inactivation by oxygen or its metabolites. NADH was normally oxidized by the oxygen-inactivated enzyme, which rules out damage to the flavin adenine dinucleotide cofactor. Hydrogen peroxide partially inactivated the molybdenum center of XOR, as shown by a parallel decrease in XOR-catalyzed xanthine oxidation and dichlorophenolindophenol reduction. We conclude that the transcription or translation of XOR is not influenced by hypoxia or hyperoxia. Instead, the molybdenum center of XOR is posttranslationally inactivated by oxygen metabolites in "normal" (21% O2) cell culture atmosphere. This inactivation is reversed in hypoxia and accounts for the apparent induction.

xanthine oxidase; hypoxia; hyperoxia; ischemia reperfusion



Address for reprint requests and other correspondence: N. Linder, Research Program for Developmental and Reproductive Biology, Univ. of Helsinki, Biomedicum Helsinki, Rm. B524b, Haartmaninkatu 8, 00290 Helsinki, Finland. (E-mail: nina.linder{at}hus.fi).




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Boueiz, M. Damarla, and P. M. Hassoun
Xanthine oxidoreductase in respiratory and cardiovascular disorders
Am J Physiol Lung Cell Mol Physiol, May 1, 2008; 294(5): L830 - L840.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
N Linder, C Haglund, M Lundin, S Nordling, A Ristimaki, A Kokkola, J Mrena, J-P Wiksten, and J Lundin
Decreased xanthine oxidoreductase is a predictor of poor prognosis in early-stage gastric cancer.
J. Clin. Pathol., September 1, 2006; 59(9): 965 - 971.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. E. Griguer, C. R. Oliva, E. E. Kelley, G. I. Giles, J. R. Lancaster Jr., and G. Y. Gillespie
Xanthine Oxidase-Dependent Regulation of Hypoxia-Inducible Factor in Cancer Cells
Cancer Res., February 15, 2006; 66(4): 2257 - 2263.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. M. Saraiva, K. M. Minhas, S. V.Y. Raju, L. A. Barouch, E. Pitz, K. H. Schuleri, K. Vandegaer, D. Li, and J. M. Hare
Deficiency of Neuronal Nitric Oxide Synthase Increases Mortality and Cardiac Remodeling After Myocardial Infarction: Role of Nitroso-Redox Equilibrium
Circulation, November 29, 2005; 112(22): 3415 - 3422.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. Linder, J. Lundin, J. Isola, M. Lundin, K. O. Raivio, and H. Joensuu
Down-Regulated Xanthine Oxidoreductase Is a Feature of Aggressive Breast Cancer
Clin. Cancer Res., June 15, 2005; 11(12): 4372 - 4381.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
J. E. Conour, W. V. Graham, and H. R. Gaskins
A combined in vitro/bioinformatic investigation of redox regulatory mechanisms governing cell cycle progression
Physiol Genomics, July 8, 2004; 18(2): 196 - 205.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.